Showing results (1-10 of 903) with videos related to
Sort By:
Pageof 91
International Journal of Antimicrobial Agents|November 30, 2002
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000D J Diekema, M A Pfaller, R N Jones, et al.Diagnostic Microbiology and Infectious Disease|October 26, 1999
Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitalsL M Deshpande, D J Diekema, R N JonesDiagnostic Microbiology and Infectious Disease|May 26, 1999
Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centersD J Diekema, R N Jones, K V RolstonClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 25, 2001
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin AmericaD J Diekema, M L Beach, M A Pfaller, et al.Journal of Clinical Microbiology|September 28, 2001
Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococciT Yamazumi, I Furuta, D J Diekema, et al.Journal of Clinical Microbiology|August 9, 2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungiD J Diekema, S A Messer, R J Hollis, et al.Antimicrobial Agents and Chemotherapy|February 27, 2003
In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolatesM A Pfaller, D J Diekema, S A Messer, et al.Journal of Clinical Microbiology|March 7, 2002
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000M A Pfaller, D J Diekema, R N Jones, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida sppM A Pfaller, S A Messer, R J Hollis, et al.Pageof 91